Instil Bio
49 hedge funds and large institutions have $358M invested in Instil Bio in 2024 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 8 closing their positions.
723% more capital invested
Capital invested by funds: $43.5M → $358M (+$315M)
238% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 8
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
63% more funds holding
Funds holding: 30 → 49 (+19)
16.78% more ownership
Funds ownership: 65.04% → 81.82% (+17%)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$8.37M |
| 2 |
PA
Perceptive Advisors
New York
|
+$8.14M |
| 3 |
CC
Commodore Capital
New York
|
+$3.55M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$3.42M |
| 5 |
SCM
Superstring Capital Management
New York
|
+$2.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCC
Cable Car Capital
San Francisco,
California
|
-$2.66M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$2.52M |
| 3 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$1.32M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$876K |
| 5 |
Renaissance Technologies
New York
|
-$457K |
TIL Hedge Fund Activity: Q3 2024 in Review
49 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Instil Bio (TIL) for Q3 2024, worth a combined $358M — up 723% from $43.5M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new TIL positions and 8 closed out — a net gain of 19 holders — while 5 added to existing stakes and 9 trimmed.
The largest buyer was Boxer Capital, opening a new position worth an estimated $8.37M. The largest seller was Cable Car Capital, exiting entirely with an estimated $2.66M sold.
- 49 institutional investors held Instil Bio (TIL) as of Q3 2024, up from 30 in Q2 2024.
- Funds reported $358M of Instil Bio stock for Q3 2024, up 723% quarter-over-quarter.
- 27 funds opened new Instil Bio positions in Q3 2024 and 8 closed out, a net change of +19 holders.
- The largest Instil Bio buyer in Q3 2024 was Boxer Capital, an estimated $8.37M added.
- The largest Instil Bio seller in Q3 2024 was Cable Car Capital, an estimated $2.66M sold.
Based on aggregated 13F filings for Q3 2024.